ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia-Reference-Cited by-同舟云学术

ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia

Published:2007-04-06 Issue:4 Volume:3 Page:e46
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Maldarelli Frank,Palmer Sarah,King Martin S,Wiegand Ann,Polis Michael A,Mican JoAnn,Kovacs Joseph A,Davey Richard T,Rock-Kress Diane,Dewar Robin,Liu Shuying,Metcalf Julia A,Rehm Catherine,Brun Scott C,Hanna George J,Kempf Dale J,Coffin John M,Mellors John W

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference33 articles.

1. In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months.;J Virol,2003

2. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.;JAMA,1999

3. Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy.;J Virol,2003

4. Residual HIV-1 persistence during suppressive HAART.;Curr Clin Top Infect Dis,2001

5. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.;Science,1997

Cited by 288 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No evidence for ongoing replication on ART in SIV-infected macaques;Nature Communications;2024-06-14

2. HIV-1 controllers possess a unique CD8+ T-cell activation phenotype and loss of control is associated with increased expression of exhaustion markers;2024-04-12

3. HIV Expression in Infected T Cell Clones;Viruses;2024-01-11

4. Extracellular vesicles as carriers of mRNA: Opportunities and challenges in diagnosis and treatment;Theranostics;2024

5. Interleukin-36gamma Mediates the In Vitro Activation of CD8⁺ T Cells from Patients Living with Chronic Human Immunodeficiency Virus-1 Infection;Viral Immunology;2024-01-01